← Back to Search

HIV with NAFLD for Fatty Liver Disease (Theratech Trial)

N/A
Waitlist Available
Led By Giada Sebastiani
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 years old at screening;
Able to provide informed consent, in French or English;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Theratech Trial Summary

To determine the distribution of visceral fat in people living with HIV (PLHIV) with NAFLD by clinical anthropometric indicators (wais-to-hip ratio), lipid accumulation product (waist circumference and triglycerides) and radiological techniques such as dual-energy X-ray absorptiometry (DXA) (trunk fat mass and fat mass through dual-energy X-ray absorptiometry).

Eligible Conditions
  • Fatty Liver Disease
  • HIV (Human Immunodeficiency Virus)
  • Non-alcoholic Fatty Liver Disease

Theratech Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Theratech Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determination of visceral fat

Theratech Trial Design

2Treatment groups
Active Control
Group I: HIV with NAFLDActive Control3 Interventions
HIV Nonalcoholic fatty liver disease patients
Group II: HIV without NAFLDActive Control3 Interventions
HIV without Nonalcoholic fatty liver disease patients

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
438 Previous Clinical Trials
159,018 Total Patients Enrolled
Giada SebastianiPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
2 Previous Clinical Trials
67 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Mar 2025